SCHEMBL30002368

SCHEMBL30002368

CC(=O)N1CCN(c2ccc(N)c(NC(=O)OC(C)(C)C)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.49
GFER P55789 1/20 0.49
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HDAC1 Q13547 6/20 0.45
HDAC2 Q92769 6/20 0.45
HDAC3 O15379 4/20 0.45
USP2 O75604 1/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALK Q9UM73 5/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
NPC1 O15118 1/20 0.42
PKM P14618 1/20 0.42
AAK1 Q2M2I8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600816 1.00 CASP6 (0.49) CASP6GFERMAPTMEN1KMT2A
SCHEMBL30331532 0.90 HDAC1 (0.42) CASP6GFERMEN1KMT2AHDAC1
SCHEMBL25140046 0.90 HDAC1 (0.42) CASP6GFERMEN1KMT2AHDAC1
SCHEMBL12466602 0.88 MAPT (0.51) MAPTMEN1KMT2AHDAC1HDAC2
SCHEMBL21600746 0.88 HDAC1 (0.52) GFERMAPTMEN1KMT2AHDAC1
SCHEMBL16071545 0.87 HDAC1 (0.51) GFERMAPTMEN1KMT2AHDAC1
SCHEMBL28533516 0.86 HDAC1 (0.40) MAPTMEN1KMT2AHDAC1HDAC2
SCHEMBL30043568 0.85 AAK1 (0.43) MAPTHDAC1HDAC2HDAC3MAPK1
SCHEMBL23606833 0.85 AAK1 (0.43) MAPTHDAC1HDAC2HDAC3MAPK1
SCHEMBL16071685 0.85 GAA (0.51) GFERMAPTMEN1KMT2AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220332687-A1 HETEROARYL COMPOUNDS AND USES THEREOF SANOFI (FR) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332687-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 CASP6 2878/4885GFER 2462/4885MAPT 1888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.